tiprankstipranks
ODI Pharma AB (DE:6OD)
FRANKFURT:6OD
Germany Market
6OD
ODI Pharma AB
RESEARCH TOOLSreports

ODI Pharma AB (6OD) Financial Statements

0 Followers

ODI Pharma AB Financial Overview

ODI Pharma AB's market cap is currently €3.84M. The company's EPS TTM is €; its P/E ratio is -153.85; ODI Pharma AB is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement
Total Revenue
Gross Profit$ -103.64K$ 0.00--
Operating Income$ -7.21M$ -3.96M$ -4.93M$ -3.34M
EBITDA$ -7.20M$ -3.95M$ -4.92M$ -3.34M
Net Income$ -7.24M$ -3.98M$ -4.96M$ -3.63M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 10.50M$ 16.88M$ 20.86M$ 4.47M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -7.37M$ -14.62M$ -20.51M$ -4.42M
Total Liabilities$ 1.24M$ 581.73K$ 785.67K$ 425.99K
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -7.38M$ -6.06M$ -4.77M$ -3.37M
Operating Cash Flow$ -7.37M$ -6.06M$ -4.75M$ -3.36M
Investing Cash Flow
Financing Cash Flow

ODI Pharma AB Earnings and Revenue History

Income Statement >

ODI Pharma AB Debt to Assets

Balance Sheet >

ODI Pharma AB Cash Flow

Cash Flow >

ODI Pharma AB Forecast EPS vs Actual EPS

Earnings >